Long-term neurological manifestations of COVID-19: prevalence and predictive factors.

Saved in:
Bibliographic Details
Title: Long-term neurological manifestations of COVID-19: prevalence and predictive factors.
Authors: Pilotto, Andrea (AUTHOR), Cristillo, Viviana (AUTHOR), Cotti Piccinelli, Stefano (AUTHOR), Zoppi, Nicola (AUTHOR), Bonzi, Giulio (AUTHOR), Sattin, Davide (AUTHOR), Schiavolin, Silvia (AUTHOR), Raggi, Alberto (AUTHOR), Canale, Antonio (AUTHOR), Gipponi, Stefano (AUTHOR), Libri, Ilenia (AUTHOR), Frigerio, Martina (AUTHOR), Bezzi, Michela (AUTHOR), Leonardi, Matilde (AUTHOR), Padovani, Alessandro (AUTHOR)
Source: Neurological Sciences. Dec2021, Vol. 42 Issue 12, p4903-4907. 5p. 1 Chart, 1 Graph.
Subjects: Neurologic manifestations of general diseases, COVID-19, Logistic regression analysis, Symptoms, SARS-CoV-2, Psychological manifestations of general diseases, Morbid obesity
Abstract: Background: Clinical investigations have argued for long-term neurological manifestations in both hospitalised and non-hospitalised COVID-19 patients. It is unclear whether long-term neurological symptoms and features depend on COVID-19 severity. Methods: From a sample of 208 consecutive non-neurological patients hospitalised for COVID-19 disease, 165 survivors were re-assessed at 6 months according to a structured standardised clinical protocol. Prevalence and predictors of long-term neurological manifestations were evaluated using multivariate logistic regression analyses. Results: At 6-month follow-up after hospitalisation due to COVID-19 disease, patients displayed a wide array of symptoms; fatigue (34%), memory/attention (31%) and sleep disorders (30%) were the most frequent. At neurological examination, 40% of patients exhibited neurological abnormalities, such as hyposmia (18.0%), cognitive deficits (17.5%), postural tremor (13.8%) and subtle motor/sensory deficits (7.6%). Older age, premorbid comorbidities and severity of COVID-19 were independent predictors of neurological manifestations in logistic regression analyses. Conclusions: Premorbid vulnerability and severity of SARS-CoV-2 infection impact on prevalence and severity of long-term neurological manifestations. [ABSTRACT FROM AUTHOR]
Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Description
Abstract:Background: Clinical investigations have argued for long-term neurological manifestations in both hospitalised and non-hospitalised COVID-19 patients. It is unclear whether long-term neurological symptoms and features depend on COVID-19 severity. Methods: From a sample of 208 consecutive non-neurological patients hospitalised for COVID-19 disease, 165 survivors were re-assessed at 6 months according to a structured standardised clinical protocol. Prevalence and predictors of long-term neurological manifestations were evaluated using multivariate logistic regression analyses. Results: At 6-month follow-up after hospitalisation due to COVID-19 disease, patients displayed a wide array of symptoms; fatigue (34%), memory/attention (31%) and sleep disorders (30%) were the most frequent. At neurological examination, 40% of patients exhibited neurological abnormalities, such as hyposmia (18.0%), cognitive deficits (17.5%), postural tremor (13.8%) and subtle motor/sensory deficits (7.6%). Older age, premorbid comorbidities and severity of COVID-19 were independent predictors of neurological manifestations in logistic regression analyses. Conclusions: Premorbid vulnerability and severity of SARS-CoV-2 infection impact on prevalence and severity of long-term neurological manifestations. [ABSTRACT FROM AUTHOR]
ISSN:15901874
DOI:10.1007/s10072-021-05586-4